Temporary Transportation Surcharge
- 2.5 Minutes to read
- Written by Axonlab Österreich
- Corporate
Dear Customer,
The aftermath of the pandemic in the global production and supply chains is still being felt on a massive scale, and just when we thought things would soon get better, the next massive disruption comes our way with the war in Ukraine.
In addition to all the human suffering from both events, now come the economic effects that directly affect us all. Specifically, there are two major issues that unfortunately force us to correct prices again. On the one hand the production bottlenecks, which of course do not stop at medical products, and on the other hand the import transport costs, which have increased 4-fold in some cases due to the war in Ukraine.
The flight bans over Russia, the quasi suspension of the long-distance route via the Trans-Siberian Railway, lockdown of the Shanghai airport hub, high diesel and kerosene prices, etc. - news from international forwarders reach us daily. Also our suppliers from Europe or USA are waiting for preliminary products from China, Japan, Korea, Taiwan.
But before we increase the prices in general, we would like to work with a temporary transport cost surcharge, which we unfortunately have to charge on every delivery in the future. The temporary transport cost surcharge will only apply as long as the situation is as acute as it is nowadays. As soon as the price level permits, we intend to gradually reduce this surcharge again. The temporary transport cost surcharge has been calculated by us with currently € 14,- per delivery. This allows us to absorb 50% of the cost increase. The remaining 50% will be borne by Axonlab as long as we are able to do so.
We suggest that you increase your order quantities slightly and order less often. This will help you and us to save costs. However, please note that we cannot take back over-ordered or expired goods.
We would like to ask you again for your understanding that it is not possible for us to completely compensate such explosively increased costs.
With kind regards,
Thomas Haller
Executive Board Axon Lab AG